[Antibacterial activity of lincomycin in diseases of the maxillofacial region].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D005145:Face; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D008034:Lincomycin / Q000494:pharmacology / Q000627:therapeutic use*; D008439:Maxillary Diseases / Q000188:drug therapy* / Q000382:microbiology; D010403:Penicillin Resistance; D010482:Periapical Abscess / Q000188:drug therapy* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013492:Suppuration / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D008034:Lincomycin
Die antibakterielle Wirksamkeit des Lincomycin bei Erkrankungen im Kiefer-Gesichtsbereich.